Verastem Inc (VSTM)
11.85
-0.07
(-0.59%)
USD |
NASDAQ |
May 10, 16:00
11.82
-0.03
(-0.25%)
After-Hours: 20:00
Verastem Cash from Financing (Quarterly): -0.446M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.446M |
| September 30, 2023 | -0.891M |
| June 30, 2023 | 91.48M |
| March 31, 2023 | 44.05M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 25.62M |
| June 30, 2022 | 0.708M |
| March 31, 2022 | 25.45M |
| December 31, 2021 | 6.805M |
| September 30, 2021 | 0.169M |
| June 30, 2021 | 0.489M |
| March 31, 2021 | -0.578M |
| December 31, 2020 | -36.61M |
| September 30, 2020 | 0.137M |
| June 30, 2020 | 12.68M |
| March 31, 2020 | 93.42M |
| December 31, 2019 | -12.70M |
| September 30, 2019 | 0.494M |
| June 30, 2019 | 9.694M |
| March 31, 2019 | 0.075M |
| December 31, 2018 | 145.47M |
| September 30, 2018 | 0.074M |
| June 30, 2018 | 115.32M |
| March 31, 2018 | 0.299M |
| December 31, 2017 | 46.72M |
| Date | Value |
|---|---|
| September 30, 2017 | 14.21M |
| June 30, 2017 | -0.138M |
| March 31, 2017 | 2.386M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.005M |
| December 31, 2015 | 0.051M |
| September 30, 2015 | 0.062M |
| June 30, 2015 | 8.122M |
| March 31, 2015 | 55.35M |
| December 31, 2014 | 9.519M |
| September 30, 2014 | -0.199M |
| June 30, 2014 | -0.059M |
| March 31, 2014 | -0.487M |
| December 31, 2013 | 0.002M |
| September 30, 2013 | 59.29M |
| June 30, 2013 | -0.034M |
| March 31, 2013 | -0.765M |
| December 31, 2012 | 0.001M |
| September 30, 2012 | 0.002M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 57.60M |
| December 31, 2011 | 19.49M |
| September 30, 2011 | 31.90M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-36.61M
Minimum
Dec 2020
93.42M
Maximum
Mar 2020
13.68M
Average
0.494M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Johnson & Johnson | 546.00M |
| Geron Corp | 147.80M |
| Altimmune Inc | 72.75M |
| Oragenics Inc | -0.1806M |
| Actinium Pharmaceuticals Inc | 14.77M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.68M |
| Cash from Investing (Quarterly) | 12.44M |
| Free Cash Flow | -86.46M |
| Free Cash Flow Per Share (Quarterly) | -1.105 |
| Free Cash Flow Yield | -33.12% |